63215-31-6

Basic information

• Product Name: 6-ISOPROPOXY-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE
• Synonyms: 6-ISOPROPOXY-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE;1(2H)-Naphthalenone, 3,4-dihydro-6-(1-methylethoxy)-
• CAS NO: 63215-31-6
• Molecular Formula: C₁₃H₁₆O₂
• Molecular Weight: 204.26
• Mol File: 63215-31-6.mol

Chemical Properties

• Boiling Point: 341.8 °C at 760 mmHg
• Flash Point: 154.1 °C
• Appearance: /
• Density: 1.074 g/cm³
• Vapor Pressure: 7.87E-05mmHg at 25°C
• Refractive Index: 1.533
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 6-ISOPROPOXY-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-ISOPROPOXY-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE(63215-31-6)
• EPA Substance Registry System: 6-ISOPROPOXY-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE(63215-31-6)

Safety Data

• Hazardous Substances Data: 63215-31-6(Hazardous Substances Data)

Usage

Uses

Used in Fragrance Industry:
6-Isopropoxy-3,4-dihydro-2h-naphthalen-1-one is used as a fragrance ingredient in perfumes, colognes, and other scented products for its long-lasting and pleasant scent.
Used in Personal Care Products:
6-Isopropoxy-3,4-dihydro-2h-naphthalen-1-one is used as a scent enhancer in deodorants, soaps, and other personal care products to provide a pleasant and lasting aroma.
Used in Cosmetics:
6-Isopropoxy-3,4-dihydro-2h-naphthalen-1-one is used in cosmetics to impart a sweet, floral, and woody scent, making the products more appealing to consumers.

InChI:InChI=1/C13H16O2/c1-9(2)15-11-6-7-12-10(8-11)4-3-5-13(12)14/h6-9H,3-5H2,1-2H3

Upstream product

• 75-30-9 2-iodo-propane 
• 3470-50-6 6-Hydroxy-1-tetralone 
• 75-26-3 isopropyl bromide 

Downstream Products

• 66361-98-6 C₂₀H₂₃NO₄S 

Relevant articles and documents

4,5-DIHYDRONAPHTHO [1,2-b] THIOPHENE DERIVATIVE

A 4,5-dihydronaphtho[1,2-b]thiophene derivative expressed by the formula: (wherein R1 is a C1 to C10 1-hydroxyalkyl group or a C1 to C10 acyl group, and R2 and R3 separately substitute in the 6-, 7-, 8-, or 9-positions, and are each independently a hydrogen atom, a halogen atom, a C1 to C10 alkyl group, a hydroxy group, a C1 to C10 alkoxy group, a C1 to C5 alkenyloxy group, a C1 to C5 alkynyloxy group, a benzyloxy group, or the like, provided that when R1 is an acyl group and R2 is a hydrogen atom, then R3 is neither a hydrogen atom nor an acetyl group), or a pharmaceutically acceptable salt thereof. This is a novel compound that is effective in reducing triglyceride levels in the liver and reducing blood glucose levels.

1,2-Dithiole derivatives and therapeutic agents containing them

Novel 1,2-dithiole-3-thione derivatives represented by general formulas (1) and (11); processes for production thereof; and therapeutic or preventive agents for diseases associated with peroxylipid, each containing said derivative as the active ingredient

A new access to 1-naphthylamines by an equivalent Semmler-Wolff reaction

A new access to 1-naphthylamines from the corresponding 3,4-dihydro-1(2H)-naphthalenones (α-tetralones) is described. It proceeds in a two-step sequence: preparation of the benzyl Schiff's base of an α-tetralone followed by aromatization over palladium ca

Synthesis of 2-(N-substituted amino)-6-hydroxy-1,2,3,4-tetrahydronaphthalen-1-ol derivatives

trans-6-Hydroxy-2-(1-methyl-3-phenylpropyl)amino-1,2,3,4-tetrahydronaphth alen-1-ol (8a), trans-6-hydroxy-2-(1-methyl-2-phenoxyethyl)amino-1,2,3,4-tetrahydronaphtha len-1-ol (8b) and trans-1,6-dihydroxy-2-(1-methyl-3-phenylpropyl)amino-1,2,3,4-tetrahydronap hthalene-5-carboxamide (9a) were synthesized as a part of our search for useful cardiovascular agents. 2-(N-Substituted amino)-6-alkoxy-1,2,3,4-tetrahydronaphthalen-1-ols (10-31) having various substituents at the 5-, 6- and 7-positions of the naphthalene ring were prepared by a five-step sequence of reactions starting from 3,4-dihydro-1(2H)-naphthalenone derivatives (36). Furthermore 2-(N-substituted amino)-1-indanol derivatives (33) and 6-(N-substituted amino)-2-hydroxy-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ols (34, 35) were obtained by the reductive alkylation of the corresponding amino alcohols with carbonyl compounds. These N-substituted amino alcohols (8-35) were tested for vasodilating activity in anesthetized dogs and for β-blocking activity using isolated guinea pig atrial preparations.